Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Breast Carcinoma In Situ × talimogene laherparepvec × 1 year × Clear all

Sponsor

Conditions

Sarcoma 4 Breast Neoplasms 3 Triple Negative Breast Neoplasms 1 Sezary Syndrome 1 Paget Disease, Extramammary 1 Neurofibromatosis 1 1 Neurofibromatoses 1 Neurofibroma 1 Neoplasm Metastasis 1 Mycosis Fungoides 1 Muir-Torre Syndrome 1 Microcystic adnexal carcinoma 1 Melanoma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, T-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Liposarcoma 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Eccrine Porocarcinoma 1 Carcinoma, Signet Ring Cell 1 Carcinoma, Merkel Cell 1 Carcinoma, Ductal, Breast 1 Carcinoma, Ductal 1 Carcinoma, Basosquamous 1 Carcinoma, Basal Cell 1 Adenocarcinoma, Papillary 1

Interventions

Specimen Handling 7 Tamoxifen 5 Practice Guidelines as Topic 5 Standard of Care 4 Radiotherapy 3 Methods 3 Sentinel Lymph Node Biopsy 2 Radiation 2 Interviews as Topic 2 Educational Status 2 Early Intervention, Educational 2 Counseling 2 pembrolizumab 1 exemestane 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 auricularum 1 abemaciclib 1 Watchful Waiting 1 Telemedicine 1 Taxes 1 Tablets 1 Surveys and Questionnaires 1 Starch 1 Reverse Transcriptase Polymerase Chain Reaction 1 Ranitidine 1 Radiosurgery 1 Radiation Dose Hypofractionation 1 Protons 1 Proton Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡